Table 4.
Sample Conc. (μg/mL) | HCT-116 Viability % |
HepG-2 Viability % |
MCF-7 Viability % |
|||
---|---|---|---|---|---|---|
Stand. | Sample | Stand. | Sample | Stand. | Sample | |
50 | 12.16 | 25.61 | 15.38 | 24.07 | 7.82 | 17.80 |
25 | 15.54 | 39.92 | 27.35 | 40.59 | 15.18 | 31.02 |
12.5 | 18.92 | 53.06 | 43.59 | 51.67 | 29.26 | 41.22 |
6.25 | 39.86 | 72.34 | 53.85 | 61.99 | 42.35 | 73.43 |
3.125 | 47.30 | 87.11 | 69.23 | 77.20 | 56.54 | 85.64 |
1.56 | 58.11 | 97.01 | 76.82 | 89.91 | 67.24 | 96.51 |
0 | 100 | 100 | 100 | 100 | 100 | 100 |